Cambridge Investment Research Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,303	Closed	-$396K	–	2372
2018 Q4	$396K	Buy	+4,303	New	+$435K	﹤0.01%	1456
2018 Q1	–	Sell	-18,652	Closed	-$1.7M	–	2257
2017 Q4	$1.7M	Buy	18,652 +894	+5%	+$74.4K	0.02%	645
2017 Q3	$1.35M	Hold	17,758	–	–	0.02%	696
2017 Q2	$1.33M	Buy	+17,758	New	+$1.23M	0.02%	673
2016 Q4	–	Sell	-5,765	Closed	-$326K	–	1839
2016 Q3	$326K	Buy	+5,765	New	+$283K	0.01%	1253

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Cambridge Investment Research Advisors's PRAH Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 4,303 shares — an estimated $396K sold.

Cambridge Investment Research Advisors first reported a position in PRAH in Q3 2016 and held it in 5 quarters. The position peaked at $1.7M in Q4 2017. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

Cambridge Investment Research Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
Cambridge Investment Research Advisors sold 4,303 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $396K.
Cambridge Investment Research Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 5 quarters.
Cambridge Investment Research Advisors's PRA Health Sciences, Inc. position peaked at $1.7M in Q4 2017.
354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.